Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Shares Issued (2020 - 2025)

Historic Shares Issued for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $118.8 million.

  • Roivant Sciences' Shares Issued rose 22106.69% to $118.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $254.2 million, marking a year-over-year increase of 343.97%. This contributed to the annual value of $49.6 million for FY2025, which is 7517.94% down from last year.
  • According to the latest figures from Q4 2025, Roivant Sciences' Shares Issued is $118.8 million, which was up 22106.69% from $68.3 million recorded in Q3 2025.
  • Roivant Sciences' Shares Issued's 5-year high stood at $199.8 million during Q4 2023, with a 5-year trough of $2.3 million in Q2 2024.
  • Moreover, its 4-year median value for Shares Issued was $52.6 million (2024), whereas its average is $75.7 million.
  • As far as peak fluctuations go, Roivant Sciences' Shares Issued crashed by 9629.74% in 2024, and later soared by 122351.39% in 2025.
  • Over the past 4 years, Roivant Sciences' Shares Issued (Quarter) stood at $94.7 million in 2022, then surged by 110.93% to $199.8 million in 2023, then tumbled by 81.48% to $37.0 million in 2024, then skyrocketed by 221.07% to $118.8 million in 2025.
  • Its Shares Issued stands at $118.8 million for Q4 2025, versus $68.3 million for Q3 2025 and $30.1 million for Q2 2025.